Geode Capital Management’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.17M | Buy |
114,555
+4,667
| +4% | +$39.3K | ﹤0.01% | 3308 |
|
|
2025
Q4 | $690K | Buy |
109,888
+5,342
| +5% | +$29.3K | ﹤0.01% | 3483 |
|
|
2025
Q3 | $312K | Hold |
104,546
| – | – | ﹤0.01% | 3787 |
|
|
2025
Q2 | $199K | Sell |
104,546
-1,291
| -1% | -$2.09K | ﹤0.01% | 3874 |
|
|
2025
Q1 | $155K | Sell |
105,837
-952
| -0.9% | -$1.9K | ﹤0.01% | 3917 |
|
|
2024
Q4 | $198K | Sell |
106,789
-277
| -0.3% | -$623 | ﹤0.01% | 3913 |
|
|
2024
Q3 | $254K | Buy |
107,066
+577
| +0.5% | +$1.48K | ﹤0.01% | 3826 |
|
|
2024
Q2 | $293K | Buy |
106,489
+6,601
| +7% | +$18.8K | ﹤0.01% | 3780 |
|
|
2024
Q1 | $418K | Sell |
99,888
-1,125
| -1% | -$4.07K | ﹤0.01% | 3677 |
|
|
2023
Q4 | $327K | Hold |
101,013
| – | – | ﹤0.01% | 3767 |
|
|
2023
Q3 | $303K | Buy |
101,013
+78,550
| +350% | +$211K | ﹤0.01% | 3810 |
|
|
2023
Q2 | $25.6K | Hold |
22,463
| – | – | ﹤0.01% | 4626 |
|
|
2023
Q1 | $37.5K | Hold |
22,463
| – | – | ﹤0.01% | 4583 |
|
|
2022
Q4 | $27K | Sell |
22,463
-65
| -0.3% | -$169 | ﹤0.01% | 4720 |
|
|
2022
Q3 | $95K | Hold |
22,528
| – | – | ﹤0.01% | 4595 |
|
|
2022
Q2 | $87K | Buy |
22,528
+307
| +1% | +$1.33K | ﹤0.01% | 4639 |
|
|
2022
Q1 | $108K | Buy |
22,221
+12,033
| +118% | +$61.6K | ﹤0.01% | 4633 |
|
|
2021
Q4 | $55K | Hold |
10,188
| – | – | ﹤0.01% | 4840 |
|
|
2021
Q3 | $36K | Hold |
10,188
| – | – | ﹤0.01% | 4808 |
|
|
2021
Q2 | $40K | Hold |
10,188
| – | – | ﹤0.01% | 4676 |
|
|
2021
Q1 | $48K | Buy |
+10,188
| New | +$50.1K | ﹤0.01% | 4409 |
|
|
2019
Q2 | – | Sell |
-5,208
| Closed | -$21K | – | 4209 |
|
|
2019
Q1 | $21K | Hold |
5,208
| – | – | ﹤0.01% | 4088 |
|
|
2018
Q4 | $15K | Hold |
5,208
| – | – | ﹤0.01% | 4113 |
|
|
2018
Q3 | $73K | Hold |
5,208
| – | – | ﹤0.01% | 3979 |
|
|
2018
Q2 | $82K | Buy |
5,208
+2,533
| +95% | +$41.2K | ﹤0.01% | 3907 |
|
|
2018
Q1 | $40K | Hold |
2,675
| – | – | ﹤0.01% | 3971 |
|
|
2017
Q4 | $37K | Hold |
2,675
| – | – | ﹤0.01% | 3955 |
|
|
2017
Q3 | $34K | Hold |
2,675
| – | – | ﹤0.01% | 3974 |
|
|
2017
Q2 | $29K | Buy |
2,675
+2,549
| +2,023% | +$61.8K | ﹤0.01% | 4014 |
|
|
2017
Q1 | $7K | Hold |
126
| – | – | ﹤0.01% | 4063 |
|
|
2016
Q4 | $7K | Hold |
126
| – | – | ﹤0.01% | 4028 |
|
|
2016
Q3 | $26K | Hold |
126
| – | – | ﹤0.01% | 3979 |
|
|
2016
Q2 | $27K | Hold |
126
| – | – | ﹤0.01% | 4000 |
|
|
2016
Q1 | $69 | Hold |
126
| – | – | ﹤0.01% | 3912 |
|
|
2015
Q4 | $70K | Hold |
126
| – | – | ﹤0.01% | 3954 |
|
|
2015
Q3 | $69K | Buy |
+126
| New | +$115K | ﹤0.01% | 3962 |
|
Other funds holding ARMP
MAM
VCM
6CM
DIG
VFT
Geode Capital Management's ARMP Position: Q1 2026 in Review
Geode Capital Management increased its Armata Pharmaceuticals (ARMP) stake by 4.2% in Q1 2026, buying an estimated $39.3K and bringing the position to 114,555 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #3308.
Geode Capital Management first reported a position in ARMP in Q3 2015 and has held it in 36 quarters since. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.
- Geode Capital Management held 114,555 shares of Armata Pharmaceuticals worth $1.17M as of Q1 2026.
- Geode Capital Management bought 4,667 Armata Pharmaceuticals shares in Q1 2026, an estimated $39.3K.
- Armata Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3308 holding.
- Geode Capital Management first reported a position in Armata Pharmaceuticals in Q3 2015 and has held it in 36 quarters since.
- 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.